001     164963
005     20240305115239.0
024 7 _ |a 10.1002/alz.12744
|2 doi
024 7 _ |a pmid:35876563
|2 pmid
024 7 _ |a 1552-5260
|2 ISSN
024 7 _ |a 1552-5279
|2 ISSN
024 7 _ |a altmetric:133122699
|2 altmetric
037 _ _ |a DZNE-2022-01367
041 _ _ |a English
082 _ _ |a 610
100 1 _ |a Georgakis, Marios K
|b 0
245 _ _ |a Cerebral small vessel disease burden and cognitive and functional outcomes after stroke: A multicenter prospective cohort study.
260 _ _ |a Hoboken, NJ
|c 2023
|b Wiley
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1709566916_22645
|2 PUB:(DE-HGF)
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
500 _ _ |a CC BY-NC
520 _ _ |a It remains unknown whether the global small vessel disease (SVD) burden predicts post-stroke outcomes.In a prospective multicenter study of 666 ischemic and hemorrhagic stroke patients, we quantified magnetic resonance imaging (MRI)-based SVD markers (lacunes, white matter hyperintensities, microbleeds, perivascular spaces) and explored associations with 6- and 12-month cognitive (battery of 15 neuropsychological tests) and functional (modified Rankin scale) outcomes.A global SVD score (range 0-4) was associated with cognitive impairment; worse performance in executive function, attention, language, and visuospatial ability; and worse functional outcome across a 12-month follow-up. Although the global SVD score did not improve prediction, individual SVD markers, assessed across their severity range, improved the calibration, discrimination, and reclassification of predictive models including demographic, clinical, and other imaging factors.SVD presence and severity are associated with worse cognitive and functional outcomes 12 months after stroke. Assessing SVD severity may aid prognostication for stroke patients.In a multi-center cohort, we explored associations of small vessel disease (SVD) burden with stroke outcomes. SVD burden associates with post-stroke cognitive and functional outcomes. A currently used score of SVD burden does not improve the prediction of poor outcomes. Assessing the severity of SVD lesions adds predictive value beyond known predictors. To add predictive value in assessing SVD in stroke patients, SVD burden scores should integrate lesion severity.
536 _ _ |a 353 - Clinical and Health Care Research (POF4-353)
|0 G:(DE-HGF)POF4-353
|c POF4-353
|f POF IV
|x 0
588 _ _ |a Dataset connected to CrossRef, PubMed, , Journals: pub.dzne.de
650 _ 7 |a cerebral small vessel disease
|2 Other
650 _ 7 |a cognitive impairment
|2 Other
650 _ 7 |a functional outcome
|2 Other
650 _ 7 |a prediction
|2 Other
650 _ 7 |a stroke
|2 Other
650 _ 2 |a Humans
|2 MeSH
650 _ 2 |a Prospective Studies
|2 MeSH
650 _ 2 |a Stroke: complications
|2 MeSH
650 _ 2 |a Stroke: pathology
|2 MeSH
650 _ 2 |a Cerebral Small Vessel Diseases: pathology
|2 MeSH
650 _ 2 |a Cognitive Dysfunction: complications
|2 MeSH
650 _ 2 |a Magnetic Resonance Imaging
|2 MeSH
650 _ 2 |a Cognition
|2 MeSH
700 1 _ |a Fang, Rong
|b 1
700 1 _ |a Düring, Marco
|0 P:(DE-2719)9000062
|b 2
700 1 _ |a Wollenweber, Frank A
|b 3
700 1 _ |a Bode, Felix J
|0 P:(DE-2719)2811949
|b 4
700 1 _ |a Stoesser, Sebastian
|0 P:(DE-2719)9000778
|b 5
700 1 _ |a Kindlein, Christine
|0 P:(DE-2719)9002345
|b 6
|u dzne
700 1 _ |a Hermann, Peter
|0 P:(DE-2719)2812183
|b 7
700 1 _ |a Liman, Thomas G
|0 P:(DE-2719)9000189
|b 8
700 1 _ |a Nolte, Christian H
|0 P:(DE-2719)9000234
|b 9
700 1 _ |a Kerti, Lucia
|0 P:(DE-2719)2811628
|b 10
700 1 _ |a Ikenberg, Benno
|b 11
700 1 _ |a Bernkopf, Kathleen
|b 12
700 1 _ |a Poppert, Holger
|b 13
700 1 _ |a Glanz, Wenzel
|0 P:(DE-2719)2811614
|b 14
700 1 _ |a Perosa, Valentina
|0 P:(DE-2719)9000985
|b 15
700 1 _ |a Janowitz, Daniel
|0 P:(DE-2719)9002557
|b 16
|u dzne
700 1 _ |a Wagner, Michael
|0 P:(DE-2719)2000057
|b 17
700 1 _ |a Neumann, Katja
|0 P:(DE-2719)2810407
|b 18
700 1 _ |a Speck, Oliver
|0 P:(DE-2719)2810706
|b 19
700 1 _ |a Dobisch, Laura
|0 P:(DE-2719)2811611
|b 20
700 1 _ |a Düzel, Emrah
|0 P:(DE-2719)2000005
|b 21
700 1 _ |a Gesierich, Benno
|0 P:(DE-2719)9001112
|b 22
700 1 _ |a Dewenter, Anna
|b 23
700 1 _ |a Spottke, Annika
|0 P:(DE-2719)2811324
|b 24
700 1 _ |a Waegemann, Karin
|0 P:(DE-2719)2814124
|b 25
700 1 _ |a Görtler, Michael
|0 P:(DE-2719)2811292
|b 26
700 1 _ |a Wunderlich, Silke
|b 27
700 1 _ |a Endres, Matthias
|0 P:(DE-2719)2811033
|b 28
700 1 _ |a Zerr, Inga
|0 P:(DE-2719)2000058
|b 29
700 1 _ |a Petzold, Gabor
|0 P:(DE-2719)2810273
|b 30
700 1 _ |a Dichgans, Martin
|0 P:(DE-2719)2000030
|b 31
|e Last author
700 1 _ |a Investigators, DEMDAS
|b 32
|e Collaboration Author
773 _ _ |a 10.1002/alz.12744
|g p. alz.12744
|0 PERI:(DE-600)2201940-6
|n 4
|p 1152 - 1163
|t Alzheimer's and dementia
|v 19
|y 2023
|x 1552-5260
856 4 _ |u https://pub.dzne.de/record/164963/files/DZNE-2022-01367.pdf
|y OpenAccess
856 4 _ |u https://pub.dzne.de/record/164963/files/DZNE-2022-01367.pdf?subformat=pdfa
|x pdfa
|y OpenAccess
909 C O |o oai:pub.dzne.de:164963
|p openaire
|p open_access
|p VDB
|p driver
|p dnbdelivery
910 1 _ |a External Institute
|0 I:(DE-HGF)0
|k Extern
|b 2
|6 P:(DE-2719)9000062
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 4
|6 P:(DE-2719)2811949
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 5
|6 P:(DE-2719)9000778
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 6
|6 P:(DE-2719)9002345
910 1 _ |a External Institute
|0 I:(DE-HGF)0
|k Extern
|b 7
|6 P:(DE-2719)2812183
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 8
|6 P:(DE-2719)9000189
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 9
|6 P:(DE-2719)9000234
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 10
|6 P:(DE-2719)2811628
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 14
|6 P:(DE-2719)2811614
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 15
|6 P:(DE-2719)9000985
910 1 _ |a External Institute
|0 I:(DE-HGF)0
|k Extern
|b 16
|6 P:(DE-2719)9002557
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 17
|6 P:(DE-2719)2000057
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 18
|6 P:(DE-2719)2810407
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 19
|6 P:(DE-2719)2810706
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 20
|6 P:(DE-2719)2811611
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 21
|6 P:(DE-2719)2000005
910 1 _ |a External Institute
|0 I:(DE-HGF)0
|k Extern
|b 22
|6 P:(DE-2719)9001112
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 24
|6 P:(DE-2719)2811324
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 25
|6 P:(DE-2719)2814124
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 26
|6 P:(DE-2719)2811292
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 28
|6 P:(DE-2719)2811033
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 29
|6 P:(DE-2719)2000058
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 30
|6 P:(DE-2719)2810273
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 31
|6 P:(DE-2719)2000030
913 1 _ |a DE-HGF
|b Gesundheit
|l Neurodegenerative Diseases
|1 G:(DE-HGF)POF4-350
|0 G:(DE-HGF)POF4-353
|3 G:(DE-HGF)POF4
|2 G:(DE-HGF)POF4-300
|4 G:(DE-HGF)POF
|v Clinical and Health Care Research
|x 0
914 1 _ |y 2023
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0160
|2 StatID
|b Essential Science Indicators
|d 2021-01-28
915 _ _ |a Creative Commons Attribution-NonCommercial CC BY-NC 4.0
|0 LIC:(DE-HGF)CCBYNC4
|2 HGFVOC
915 _ _ |a DEAL Wiley
|0 StatID:(DE-HGF)3001
|2 StatID
|d 2021-01-28
|w ger
915 _ _ |a WoS
|0 StatID:(DE-HGF)0113
|2 StatID
|b Science Citation Index Expanded
|d 2021-01-28
915 _ _ |a OpenAccess
|0 StatID:(DE-HGF)0510
|2 StatID
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b ALZHEIMERS DEMENT : 2022
|d 2023-10-25
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
|d 2023-10-25
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
|d 2023-10-25
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Clarivate Analytics Master Journal List
|d 2023-10-25
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
|d 2023-10-25
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1110
|2 StatID
|b Current Contents - Clinical Medicine
|d 2023-10-25
915 _ _ |a IF >= 10
|0 StatID:(DE-HGF)9910
|2 StatID
|b ALZHEIMERS DEMENT : 2022
|d 2023-10-25
920 1 _ |0 I:(DE-2719)5000022
|k AG Dichgans
|l Vascular Cognitive Impairment & Post-Stroke Dementia
|x 0
920 1 _ |0 I:(DE-2719)1013020
|k AG Petzold
|l Vascular Neurology
|x 1
920 1 _ |0 I:(DE-2719)1011101
|k Patient Studies Bonn
|l Patient Studies Bonn
|x 2
920 1 _ |0 I:(DE-2719)1811005
|k AG Endres
|l Interdisciplinary Dementia Research
|x 3
920 1 _ |0 I:(DE-2719)5000006
|k AG Düzel
|l Clinical Neurophysiology and Memory
|x 4
920 1 _ |0 I:(DE-2719)1340013
|k KAP
|l Cooperation Unit for Applied Prevention Research (KAP)
|x 5
920 1 _ |0 I:(DE-2719)1011201
|k AG Wagner
|l Neuropsychology
|x 6
920 1 _ |0 I:(DE-2719)1340009
|k AG Speck
|l Linking imaging projects iNET
|x 7
920 1 _ |0 I:(DE-2719)1011001
|k AG Klockgether
|l Patient Studies
|x 8
920 1 _ |0 I:(DE-2719)1111016
|k AG Levin
|l Clinical Neurodegeneration
|x 9
920 1 _ |0 I:(DE-2719)1440011-1
|k AG Zerr
|l Translational Studies and Biomarker
|x 10
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a I:(DE-2719)5000022
980 _ _ |a I:(DE-2719)1013020
980 _ _ |a I:(DE-2719)1011101
980 _ _ |a I:(DE-2719)1811005
980 _ _ |a I:(DE-2719)5000006
980 _ _ |a I:(DE-2719)1340013
980 _ _ |a I:(DE-2719)1011201
980 _ _ |a I:(DE-2719)1340009
980 _ _ |a I:(DE-2719)1011001
980 _ _ |a I:(DE-2719)1111016
980 _ _ |a I:(DE-2719)1440011-1
980 _ _ |a UNRESTRICTED
980 1 _ |a FullTexts


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21